Powder: -20°C for 3 years
In solvent: -80°C for 2 years
RG-12915 is a selective antagonist of 5-HT3(IC50 value of 0.16 nM).
Description | RG-12915 is a selective antagonist of 5-HT3(IC50 value of 0.16 nM). |
Targets&IC50 | 5-HT3:0.16 nM |
In vitro | RG 12915 is a displacer of binding of 5-hydroxytryptamine (5-HT3) binding sites with IC50 value of 0.16 nM, whereas failing to displace binding of ligands for the alpha-1, alpha-2 and beta adrenergic, 5-HT1 or 5-HT2 or cholinergic-muscarinic sites (IC50 values less than 1 μM). |
In vivo | RG 12915 (1 mg/kg, p.o.) is highly protective against cisplatin-induced emesis in the dog. RG 12915 has no significant gastroprokinetic activity in the same species. RG 12915 has a lower ED50 value for attenuating cisplatin-induced emetic episodes in the ferret[1]. |
Molecular Weight | 360.88 |
Formula | C20H25ClN2O2 |
CAS No. | 136174-04-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RG-12915 136174-04-4 GPCR/G Protein Neuroscience 5-HT Receptor RG 12915 RG12915 Inhibitor inhibitor inhibit